Eli Lilly, Junshi collaborate to develop antibody therapies for Covid-19 disease

Eli Lilly has collaborated with Junshi Biosciences for the development of therapeutic antibodies to treat and prevent Covid-19, the disease resulted due to the SARS-CoV-2 novel coronavirus.